» Articles » PMID: 36681772

Single-cell RNA Binding Protein Regulatory Network Analyses Reveal Oncogenic HNRNPK-MYC Signalling Pathway in Cancer

Overview
Journal Commun Biol
Specialty Biology
Date 2023 Jan 21
PMID 36681772
Authors
Affiliations
Soon will be listed here.
Abstract

RNA-binding proteins (RBPs) are key players of gene expression and perturbations of RBP-RNA regulatory network have been observed in various cancer types. Here, we propose a computational method, RBPreg, to identify the RBP regulators by integration of single cell RNA-Seq (N = 233,591) and RBP binding data. Pan-cancer analyses suggest that RBP regulators exhibit cancer and cell specificity and perturbations of RBP regulatory network are involved in cancer hallmark-related functions. We prioritize an oncogenic RBP-HNRNPK, which is highly expressed in tumors and associated with poor prognosis of patients. Functional assays performed in cancer cells reveal that HNRNPK promotes cancer cell proliferation, migration, and invasion in vitro and in vivo. Mechanistic investigations further demonstrate that HNRNPK promotes tumorigenesis and progression by directly binding to MYC and perturbed the MYC targets pathway in lung cancer. Our results provide a valuable resource for characterizing RBP regulatory networks in cancer, yielding potential biomarkers for precision medicine.

Citing Articles

Insights into the role of hnRNPK in spermatogenesis via the piRNA pathway.

Xu H, Guo J, Huang Y, Zhang M, Wang Y, Xia L Sci Rep. 2025; 15(1):6438.

PMID: 39987352 PMC: 11846892. DOI: 10.1038/s41598-025-91081-1.


Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma.

Yang M, Ke Z, Wang D Open Life Sci. 2024; 19(1):20220975.

PMID: 39479349 PMC: 11524390. DOI: 10.1515/biol-2022-0975.


Development and validation of AI/ML derived splice-switching oligonucleotides.

Fronk A, Manzanares M, Zheng P, Geier A, Anderson K, Stanton S Mol Syst Biol. 2024; 20(6):676-701.

PMID: 38664594 PMC: 11148135. DOI: 10.1038/s44320-024-00034-9.


Editorial: RNA-binding proteins in cancer: advances in translational research.

Mancarella C, Bley N, Penalva L Front Cell Dev Biol. 2024; 12:1390044.

PMID: 38523626 PMC: 10957735. DOI: 10.3389/fcell.2024.1390044.


Prediction of protein-RNA interactions from single-cell transcriptomic data.

Fiorentino J, Armaos A, Colantoni A, Tartaglia G Nucleic Acids Res. 2024; 52(6):e31.

PMID: 38364867 PMC: 11014251. DOI: 10.1093/nar/gkae076.


References
1.
Xu L, Zhang B, Li W . Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2. Mol Med Rep. 2021; 23(4). PMC: 7893694. DOI: 10.3892/mmr.2021.11902. View

2.
Imrichova H, Hulselmans G, Atak Z, Potier D, Aerts S . i-cisTarget 2015 update: generalized cis-regulatory enrichment analysis in human, mouse and fly. Nucleic Acids Res. 2015; 43(W1):W57-64. PMC: 4489282. DOI: 10.1093/nar/gkv395. View

3.
Xu K, Cai Y, Zhang M, Zou H, Chang Z, Li D . Pan-cancer characterization of expression and clinical relevance of mA-related tissue-elevated long non-coding RNAs. Mol Cancer. 2021; 20(1):31. PMC: 7869475. DOI: 10.1186/s12943-021-01324-8. View

4.
. Pan-cancer analysis of whole genomes. Nature. 2020; 578(7793):82-93. PMC: 7025898. DOI: 10.1038/s41586-020-1969-6. View

5.
Qian J, Olbrecht S, Boeckx B, Vos H, Laoui D, Etlioglu E . A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 2020; 30(9):745-762. PMC: 7608385. DOI: 10.1038/s41422-020-0355-0. View